47 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:19pm
of patient recruitment and enrollment; uncertain dosing issues; inability or unwillingness of medical investigators to follow clinical protocols; variability
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
than expected trial subject rates of patient recruitment and enrollment, or other failures to recruit and enroll subjects, which could be particularly … , the Company announced that dosing of human subjects had been initiated in the XRX- OXY-101 PK Clinical Study. In addition, successful recruitment
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:15pm
trial sites; slow rates of patient recruitment and enrollment; uncertain dosing issues; inability or unwillingness of medical investigators to follow
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:12pm
of patient recruitment and enrollment; uncertain dosing issues; inability or unwillingness of medical investigators to follow clinical protocols; variability
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
;
slower than expected trial subject rates of patient recruitment and enrollment, or other failures to recruit and enroll subjects, which could … , 2022, the Company announced that dosing of human subjects had been initiated in the XRX- OXY-101 PK Clinical Study. In addition, successful recruitment
424B3
q3kz pjls
13 Jun 24
Prospectus supplement
4:10pm
6-K
EX-99.2
fgt2kvkw5
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-99.2
aw2z he0x
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm
424B3
exfqtdv
25 Aug 23
Prospectus supplement
6:00am
424B3
5dvppa tkufm
25 Aug 23
Prospectus supplement
6:00am
6-K
EX-99.2
hrl bd4g5f897
15 Aug 23
Condensed Interim Consolidated Financial Statements
6:00am
6-K
EX-99.2
7idz3sct23czel ikhi
16 May 23
Condensed Interim Consolidated Financial Statements
9:32am
6-K
EX-99.3
majhf4wan
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.2
bl91gzm5 anz
3 Apr 23
Consolidated Financial Statements
6:05am
424B3
82qy i7fu6qgit7t188
14 Nov 22
Prospectus supplement
1:51pm